Stay updated on Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.
Latest updates to the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page
- Check2 days agoChange DetectedThe website has added a new type of intervention with verification details and updated the revision to v2.14.0, while removing the previous type of intervention from revision v2.13.3.SummaryDifference0.8%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the study's location.SummaryDifference2%
- Check53 days agoChange DetectedSeveral links related to renal cell carcinoma and clinical trial resources have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference3%
- Check60 days agoChange DetectedNew resources related to renal cell carcinoma and immunotherapy drugs Ipilimumab and Nivolumab have been added, along with links to various health and government websites.SummaryDifference0.4%
- Check68 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
Stay in the know with updates to Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Combo Immunotherapy in Non-Clear Cell RCC Clinical Trial page.